-
Product Insights
NewChagas Disease (American Trypanosomiasis) – Drugs In Development, 2024
Empower your strategies with our Chagas Disease (American Trypanosomiasis) – Drugs In Development, 2024 report and make more profitable business decisions. Chagas disease, or American trypanosomiasis is a vector-borne anthropozoonosis caused by the protozoan parasite Trypanosoma cruzi. Symptoms include swelling at the infection site, fever, fatigue, body aches, loss of appetite, nausea, diarrhea or vomiting, and swollen glands. Treatment includes antiparasitic medications. The Chagas Disease (American Trypanosomiasis) drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
NewLeishmaniasis (Kala-Azar) – Drugs In Development, 2024
Empower your strategies with our Leishmaniasis (Kala-Azar) – Drugs In Development, 2024 report and make more profitable business decisions. Leishmaniasis is an infection caused by a parasite that is spread to people through the bite of the female phlebotomine sand fly. Symptoms include weight loss, low blood counts, enlargement of the liver and spleen, and fever. Treatment includes anti-parasitic drugs. The Leishmaniasis (Kala-Azar) drugs in development market research report provide comprehensive information on the therapeutics under development for Leishmaniasis (Kala-Azar), complete...
-
Product Insights
NewChikungunya Fever – Drugs In Development, 2024
Empower your strategies with our Chikungunya Fever – Drugs In Development, 2024 report and make more profitable business decisions. Chikungunya is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes. Chikungunya virus (CHIKV) is a member of the genus Alpha virus, in the family Togaviridae. Symptoms of Chikungunya includes debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting, and rash and fever. Treatment includes use of non-steroidal...
-
Product Insights
NewHand, Foot and Mouth Disease – Drugs In Development, 2024
Empower your strategies with our Hand, Foot and Mouth Disease – Drugs In Development, 2024 report and make more profitable business decisions. Hand, foot and mouth disease (HFMD) is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, headache, loss of appetite, and ulcers in the throat (including tonsils), mouth, and tongue....
-
Product Insights
NewHearing Disorders – Drugs In Development, 2024
Empower your strategies with our Hearing Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Hearing loss is an extremely common medical condition, ranging from neonates to the elderly, progressing in incidence and severity with age; about one-third of older adults have hearing loss. Diagnosis and management require an interprofessional team that includes the general practitioner, otolaryngologist, speech therapist, audiologist, and social worker. To correctly address hearing loss, understanding the nature of hearing loss and the equipment...
-
Product Insights
NewThrombocytopenia – Drugs In Development, 2024
Empower your strategies with our Thrombocytopenia – Drugs In Development, 2024 report and make more profitable business decisions. Thrombocytopenia refers to a lower than normal platelet count in the blood. Platelets are crucial for blood clotting and preventing bleeding. Various factors can cause thrombocytopenia, including certain medications, infections, autoimmune disorders, or conditions affecting bone marrow function. Symptoms may range from mild bruising and petechiae (small red or purple spots on the skin) to more severe bleeding in the nose, gums, or...
-
Product Insights
NewDengue Fever – Drugs In Development, 2024
Empower your strategies with our Dengue Fever – Drugs In Development, 2024 report and make more profitable business decisions. Dengue is a mosquito-borne infectious disease caused by the dengue virus. Symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. In some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from the nose, gums, or under the skin. It can also become dengue shock syndrome, which causes massive bleeding and shock. Treatment includes use of...
-
Product Insights
NewSpinal Cord Injury – Drugs In Development, 2024
Empower your strategies with our Spinal Cord Injury – Drugs In Development, 2024 report and make more profitable business decisions. Spinal cord injury (SCI) is defined as damage or trauma caused to the spinal cord. SCI can lead to loss or impaired function resulting in reduced mobility or feeling. It is usually caused by trauma, transverse myelitis, polio, spina bifida, or Friedreich's ataxia. Signs and symptoms of spinal cord injury include extreme back pain or pressure in the neck, head, or...
-
Product Insights
NewGlaucoma – Drugs In Development, 2024
Empower your strategies with our Glaucoma – Drugs In Development, 2024 report and make more profitable business decisions. Glaucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow to the optic nerve. The most important risk factors include age, elevated eye pressure, African ancestry, thin cornea, and family history of glaucoma. Signs and symptoms include...
-
Product Insights
NewMycobacterium tuberculosis Infections – Drugs In Development, 2024
Empower your strategies with our Mycobacterium tuberculosis Infections – Drugs In Development, 2024 report and make more profitable business decisions. The group of infections caused by Mycobacterium tuberculosis (M. tuberculosis) are referred to as Mycobacterium tuberculosis infections, which primarily affect the lungs but can also impact other parts of the body. The symptoms include persistent cough, fever, weight loss, and night sweats. Treatment typically involves a combination of antibiotics taken over several months. M. tuberculosis infections remain a significant global health...